Oral LSD Drug Hits Phase III Endpoints in Anxiety, Depression
MedPage Today 3 views
Topic timeline
How reporting on this topic developed over time — coverage by day, outlet counts, and multi-source storylines where they exist.
Coverage evolution
Not enough independent coverage yet to show how reporting developed. The facts below are direct observations from the tracked window.
Earliest in tracked window
Oldest report in the coverage window currently tracked for this topic.
Psychedelics not yet ready for clinical use in ADHD treatment, study finds Medical Xpress · Jul 1, 2026Latest update
Most recent tracked report from MedPage Today.
Oral LSD Drug Hits Phase III Endpoints in Anxiety, Depression MedPage Today · 1h ago12 reports in date order. Not enough independent coverage yet to show a development timeline.
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow